In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
Recent studies have demonstrated a simple, potentially universal strategy to enhance vaccine potency, via intralymph node (i.LN) injection. To date, intranodal immunization studies have focused on the delivery of unadjuvanted vaccines (e.g., naked DNA, peptide, or protein). We hypothesized that comb...
Main Authors: | Jewell, Christopher M., Irvine, Darrell J, Bustamante Lopez, Sandra C |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences
2012
|
Online Access: | http://hdl.handle.net/1721.1/70020 |
Similar Items
-
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
by: Crespo, Monica P., et al.
Published: (2015) -
A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity
by: Belcher, Angela, et al.
Published: (2023) -
Structure-based programming of lymph-node targeting in molecular vaccines
by: Liu, Haipeng, et al.
Published: (2014) -
HBV and HIV expression in lymph nodes of HIV positive LAS patients: histology and in situ hybridization.
by: Pezzella, M, et al.
Published: (1989) -
The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.
by: Gibson, P, et al.
Published: (1985)